30th Sep 2005 12:52
Dechra Pharmaceuticals PLC30 September 2005 Issued by Citigate Dewe Rogerson Limited, BirminghamDate: Friday 30 September 2005 Immediate Release Dechra Pharmaceuticals PLC (the "Company" or the "Group") Annual Information Update The Report & Accounts for the year ended 30 June 2005 has been posted toshareholders. A copy of the Report and Accounts document has also been submitted to the UKListing Authority. Further copies are available on request from the CompanySecretary, Dechra Pharmaceuticals PLC, Dechra House, Jamage Industrial Estate,Talke Pits, Stoke-on-Trent, ST7 1XW or from the Group web-site (www.dechra.com). Under the new rules introduced on 1 July 2005 relating to Prospectus Directivesby the UKLA companies are required to list all regulatory news announcementsissued by the Company in the twelve month period preceding the date that thepublished Accounts are issued to shareholders. Dechra Pharmaceuticals PLC wish to advise that the following Regulatory NewsAnnouncements have been issued by the Company over the period from 1 October2004 to 30 September 2005: 30 September 2005 Annual Information Update26 September 2005 Holding(s) in Company23 September 2005 Report & Accounts for the year-ended 30 June 2005 published19 September 2005 Holding(s) in Company16 September 2005 Holding(s) in Company13 September 2005 Holding(s) in Company8 September 2005 Holding(s) in Company6 September 2005 Preliminary Results for the year-ended 30 June 200524 August 2005 Holding(s) in Company22 August 2005 Notice of Results (Final)9 August 2005 Holding(s) in Company9 August 2005 Director/PDMR Shareholding19 July 2005 Holding(s) in Company8 July 2005 Holding(s) in Company5 July 2005 Pre-Closed Period Update17 June 2005 Director Shareholding1 June 2005 Holding(s) in Company18 April 2005 Holding(s) in Company12 April 2005 Additional Listing5 April 2005 Licenses acquisition (Vetivex)1 March 2005 Interim Results for the six months ended 31 December 200321 February 2005 Holding(s) in Company17 February 2005 Worldwide Marketing Agreement (with Belcher Pharmaceuticals)9 February 2005 Pharmaceutical Product Update7 February 2005 Holding(s) in Company1 February 2005 Statement re: Joint Venture (Vetcom Open/CamDal)28 January 2005 Notice of Results (Interim)17 January 2005 Holding(s) in Company12 January 2005 Trading Update24 December 2004 Additional Listing14 December 2004 Additional Listing19 November 2004 Additional Listing9 November 2004 Additional Listing21 October 2004 AGM Statement12 October 2004 Additional Listing Further details on the information contained within the above RNS announcementscan be viewed on the London Stock Exchange website: www.londonstockexchange.comunder code: DPH. Enquiries:Steve Whitehouse, Company Secretary Dechra Pharmaceuticals PLC Tel: +44 (0) 1782 771100 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
DPH.L